These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 18303490

  • 1. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
    Parrino L, Smerieri A, Giglia F, Milioli G, De Paolis F, Terzano MG.
    Clin Neuropharmacol; 2008; 31(1):40-50. PubMed ID: 18303490
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 3. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
    Ozone M, Yagi T, Itoh H, Tamura Y, Inoue Y, Uchimura N, Sasaki M, Shimizu T, Terzano MG, Parrino L.
    Pharmacopsychiatry; 2008 May; 41(3):106-14. PubMed ID: 18484552
    [Abstract] [Full Text] [Related]

  • 4. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC.
    Sleep; 2000 Dec 15; 23(8):1087-96. PubMed ID: 11145323
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB, Roth T, Vogel GW, Walsh JK.
    J Clin Psychiatry; 1994 May 15; 55(5):192-9. PubMed ID: 8071269
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK, Soubrane C, Roth T.
    Am J Geriatr Psychiatry; 2008 Jan 15; 16(1):44-57. PubMed ID: 18165461
    [Abstract] [Full Text] [Related]

  • 7. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL.
    Pharmacopsychiatry; 1994 Jul 15; 27(4):166-75. PubMed ID: 7972349
    [Abstract] [Full Text] [Related]

  • 8. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L, Eriksson M, Cornette F, Santoro F, Muscat N, Luthinger R, Roth T.
    Sleep Med; 2009 Jun 15; 10(6):616-20. PubMed ID: 18996742
    [Abstract] [Full Text] [Related]

  • 9. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
    Blumer JL, Findling RL, Shih WJ, Soubrane C, Reed MD.
    Pediatrics; 2009 May 15; 123(5):e770-6. PubMed ID: 19403468
    [Abstract] [Full Text] [Related]

  • 10. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 15; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 11. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Hajak G, Hedner J, Eglin M, Loft H, Stórustovu SI, Lütolf S, Lundahl J, Gaboxadol Study 99775 Group.
    Sleep Med; 2009 Aug 15; 10(7):705-12. PubMed ID: 19346160
    [Abstract] [Full Text] [Related]

  • 12. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.
    Curr Med Res Opin; 2006 Sep 15; 22(9):1633-42. PubMed ID: 16968566
    [Abstract] [Full Text] [Related]

  • 13. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.
    Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I.
    Pharmacopsychiatry; 2000 Mar 15; 33(2):47-53. PubMed ID: 10761819
    [Abstract] [Full Text] [Related]

  • 14. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M, Attali P, Coquelin JP.
    Clin Ther; 1993 Mar 15; 15(1):127-36. PubMed ID: 8458042
    [Abstract] [Full Text] [Related]

  • 15. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
    Riemann D, Voderholzer U, Cohrs S, Rodenbeck A, Hajak G, Rüther E, Wiegand MH, Laakmann G, Baghai T, Fischer W, Hoffmann M, Hohagen F, Mayer G, Berger M.
    Pharmacopsychiatry; 2002 Sep 15; 35(5):165-74. PubMed ID: 12237787
    [Abstract] [Full Text] [Related]

  • 16. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
    Monti JM, Alvariño F, Monti D.
    Sleep; 2000 Dec 15; 23(8):1075-84. PubMed ID: 11145322
    [Abstract] [Full Text] [Related]

  • 17. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
    Walsh JK, Salkeld L, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2010 Jan 15; 11(1):23-30. PubMed ID: 19945340
    [Abstract] [Full Text] [Related]

  • 18. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.
    Sleep Med; 2005 Nov 15; 6(6):487-95. PubMed ID: 16230048
    [Abstract] [Full Text] [Related]

  • 19. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N, Nakajima T, Hayash K, Nose I, Hashizume Y, Ohyama T, Habukawa M, Kotorii N, Kuwahara H, Maeda H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan 15; 30(1):22-9. PubMed ID: 16048734
    [Abstract] [Full Text] [Related]

  • 20. The effect of placebo administration on the first-night effect in healthy young volunteers.
    Suetsugi M, Mizuki Y, Yamamoto K, Uchida S, Watanabe Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):839-47. PubMed ID: 17328999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.